Analysis of PEGylated Protein by Tetra Detection Size Exclusion Chromatography - Reliably detecting low amounts of high molecular weight impurities during process development and characterization of b

ADVERTISEMENT

Analysis of PEGylated Protein by Tetra Detection Size Exclusion Chromatography
Reliably detecting low amounts of high molecular weight impurities during process development and characterization of biopharmaceutical products.


BioPharm International Supplements
Volume 24, Issue 8, pp. s10-s14

REFERENCES

1. B.S. Kendrick et al., Anal. Biochem. 299 (2), 136–46 (2001).

2. J. Wen, T. Arakawa and J.S. Philo, Anal. Biochem. 240 (2), 155–166 (1996).

3. M. Kunitani and L. Kresin, J. Chromatogr. 632 (1–2), 19–28 (1993).

4. B.H. Zimm, J. Chem. Phys. 16 (12), 1099–116 (1948).

5. Cantor and Schimmel, "Other Hydrodynamic Techniques," in Biophysical Chemistry, Part II: Techniques for the study of biological structure and function (W.H. Freeman and Company, NY, 1st ed., 1980), p. 650-653.

6. C. Fee and J.M. Van Alstine, Bioconj. Chem. 15 (6), 1304–1313 (2004).

7. M.W.F. Neilen, Mass Spec. Rev. 18 (5), 309-344 (1999).

8. A.B. Chakraborty, W. Chen and J.C. Gebler, Pharm. Technol. 32 (7), 80–87 (2008).

9. K.J. Liu, Macromol. Chem. Phys. 116 (1), 146–151 (1968).

10. S. Krishnan et al., Biochemistry 41 (20), 6422–6431 (2002).

11. R.S. Rajan et al., Prot. Sci. 15 (5), 1063–1075 (2006).

12. T. Arakawa et al., J. Pharm. Sci. 99 (4), 1674–1692 (2010).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
Author Guidelines
Source: BioPharm International Supplements,
Click here